Clinical investigation for the establishment of predictive marker for therapy-related cardiovascular adverse events onset in hematologic malignancies.
Not Applicable
Recruiting
- Conditions
- hematologic malignancies
- Registration Number
- JPRN-UMIN000028091
- Lead Sponsor
- Department of Hematology, Nephrology, Rheumatology, Akita University Graduate School of Medicine.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation between the changes of xanthine oxidase activity, the absolute number of EPC in peripheral blood and the cardiovascular adverse events onset
- Secondary Outcome Measures
Name Time Method